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cellular mitogens. Once induced, D type cyclins associ-Yan Geng,1 Qunyan Yu,1
Ewa Sicinska,1,2 Manjusri Das,1 ate with CDK4 and CDK6, and phosphorylate the retino-
blastoma protein, pRB, and pRB-related proteins p107Ju¨rgen E. Schneider,3 Shoumo Bhattacharya,3
William M. Rideout III,4 Roderick T. Bronson,5 and p130 (Adams, 2001).
In contrast to growth factor-inducible D type cyclins,Humphrey Gardner,6 and Piotr Sicinski1,*
1Department of Cancer Biology the expression of E type cyclins is controlled by an
autonomous mechanism and peaks sharply at the G1/SDana-Farber Cancer Institute and
Department of Pathology border (Dulic et al., 1992; Koff et al., 1992). The two E
type cyclins, cyclin E1 (formerly called cyclin E) and theHarvard Medical School
Boston, Massachusetts 02115 recently described cyclin E2, show significant amino
acid similarity (75% within the cyclin box, 47% through-2 Department of Pathology
Brigham and Women’s Hospital out the entire coding sequence) and are coexpressed
in virtually all proliferating cells (Geng et al., 2001; GudasHarvard Medical School
Boston, Massachusetts 02115 et al., 1999; Lauper et al., 1998; Zariwala et al., 1998). E
type cyclins associate with CDK2, CDK3, and possibly3 Department of Cardiovascular Medicine
University of Oxford with other CDKs (Geisen and Moroy, 2002; Koff et al.,
1992; Lauper et al., 1998; Zariwala et al., 1998). E typeOxford OX3 7BN
United Kingdom cyclins are believed to complete phosphorylation of
pRB, initiated by the action of cyclin D-CDK complexes4 Whitehead Institute for Biomedical Research
Cambridge, Massachusetts 02142 (Harbour et al., 1999; Lundberg and Weinberg, 1998).
However, E type cyclins were shown to be critically5 Tufts University School of Veterinary Medicine
North Grafton, Massachusetts 01536 required also for proliferation of pRB-negative cells,
while ectopic overexpression of cyclin E in pRB-nega-6 Biogen
Cambridge, Massachusetts 02142 tive cells accelerates their cell cycle (Kelly et al., 1998;
Ohtsubo et al., 1995). These observations reveal that E
type cyclins control cell cycle progression also through
pRB-independent targets. Among putative cyclin E-CDKSummary
substrates are proteins involved in the initiation of DNA
replication (Arata et al., 2000), proteins governing cen-E type cyclins (E1 and E2) are believed to drive cell
entry into the S phase. It is widely assumed that the two trosome duplication (nucleophosmin) (Hinchcliffe et al.,
1999; Okuda et al., 2000), histone biosynthesis (p220NPAT)E type cyclins are critically required for proliferation of
all cell types. Here, we demonstrate that E type cyclins (Ma et al., 2000; Zhao et al., 2000), and cell cycle progres-
sion (p27Kip1, CDC25) (Hoffmann et al., 1994; Sheaff etare largely dispensable for mouse development. How-
ever, endoreplication of trophoblast giant cells and al., 1997). Thus, it is currently assumed that cyclin
D-CDK and cyclin E-CDK enzymes have distinct func-megakaryocytes is severely impaired in the absence
of cyclin E. Cyclin E-deficient cells proliferate actively tions in regulating G1 progression, with cyclin D coupling
extracellular signals to the cell cycle machinery via pRBunder conditions of continuous cell cycling but are
unable to reenter the cell cycle from the quiescent G0 phosphorylation, while cyclin E controls the initiation of
DNA replication, centrosome duplication, and possiblystate. Molecular analyses revealed that cells lacking
cyclin E fail to normally incorporate MCM proteins into other functions. Importantly, it is widely believed that E
type cyclins are absolutely required for cell cycle pro-DNA replication origins during G0→S progression. We
also found that cyclin E-deficient cells are relatively gression of all cell types. The work presented below
challenges this notion and reveals that our understand-resistant to oncogenic transformation. These findings
define a molecular function for E type cyclins in cell ing of the cell cycle machinery needs to be reevaluated.
cycle reentry and reveal a differential requirement for
cyclin E in normal versus oncogenic proliferation. Results
Introduction Generation of Cyclin E1- and Cyclin
E2-Deficient Mice
Cyclins are key components of the core cell cycle ma- In order to rigorously test the requirement for E type
chinery. These proteins constitute regulatory subunits cyclins in development and in oncogenesis, we gener-
that bind, activate, and provide substrate specificity for ated mice lacking cyclin E1 or cyclin E2, using gene
their associated cyclin-dependent kinases (CDKs). Two targeting in embryonal stem cells. In our strategy for
classes of cyclins operate during the G1 phase in mam- cyclin E1 targeting, we deleted coding exons 2–11. In
malian cells: D type cyclins (D1, D2, and D3) and E case of cyclin E2 targeting, we deleted coding exons
type cyclins (E1 and E2) (Sherr and Roberts, 1999). The 1–8 (Figure 1A). Homozygous cyclin E1/ and E2/
expression of D type cyclins is controlled by the extra- mice were generated using standard methods, and the
absence of the deleted exons was verified by Southern
blotting (Figures 1B and 1C).*Correspondence: peter_sicinski@dfci.harvard.edu
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ment of male germ cells and suggest a role for cyclin
E2 in the meiosis that takes place in this compartment.
Importantly, cyclin E2-deficient females develop nor-
mally and are fully fertile. Moreover, all other compart-
ments analyzed develop normally in cyclin E2/ mice
(data not shown), and mutant animals display normal
life spans.
To further probe the requirement for E type cyclins in
development, we crossed cyclin E1- and E2-deficient
mice, and we generated mice expressing only a single
cyclin E allele, namely cyclin E1/E2/ and cyclin
E1/E2/ animals. We found that cyclin E1/E2/
mice (like cyclin E1/ animals) were indistinguishable
from control mice and displayed normal morphogenesis
in all tissues. On the other hand, cyclin E1/E2/ ani-
mals resembled cyclin E2/mice and displayed testicu-
lar hypoplasia and male infertility, which was more pro-
nounced than that of mice lacking only cyclin E2 (data
not shown). Collectively, these phenotypic analyses
suggested to us that the two E type cyclins perform
overlapping functions in the cell cycle progression and
that a single cyclin E allele is sufficient to afford normal
Figure 1. Targeted Inactivation of the Cyclin E1 and E2 Genes proliferation and development in mice. An alternative
(A) Top: cyclin E1 gene targeting strategy. Bottom: cyclin E2 gene explanation would be that the proliferation of the devel-
targeting strategy. The coding exons are shown as filled boxes. oping tissues does not require E type cyclins. However,
Neo, the neomycin phosphotransferase gene; Puro, the puromycin this notion would be incompatible with our current un-
resistance gene; arrows show transcriptional orientation. The re- derstanding of the cell cycle progression.
striction map of the cyclin E2 locus was provided by Drs. B. Amati
and A. Beck.
(B) Southern blot analysis of genomic DNA extracted from wild-type Requirement for E Type Cyclins in the
(WT), cyclin E1/, and cyclin E1/ mice, digested with ScaI and Endoreplication of Trophoblast Giant Cells
SpeI, and hybridized with murine cyclin E1 cDNA probe containing We further intercrossed cyclin E-deficient animals in
exons 4–12 and the 3 untranslated region. Note the absence of the order to generate cyclin E1/E2/ mice. No double
7.6 and 2.6 kb exon-containing bands and the appearance of a
mutant mice were born live, prompting us to collectnovel band of 2.8 kb in cyclin E1/ DNA.
embryos at different stages of development. We found(C) Southern blot analysis of genomic DNA extracted from WT, cyclin
E2/, and cyclin E2/ mice, digested with EcoRI, and hybridized the expected fractions of live cyclin E1/E2/ embryos
with murine cyclin E2 cDNA probe containing exons 1–6. Note the until day 10.25 of gestation (Figure 3A). At embryonic
absence of the exon-containing 9.0 kb band in cyclin E2/ DNA. day (E)10.75, approximately 50% of cyclin E1/E2/
conceptuses were alive, and these mutant embryos ap-
peared growth retarded, as compared with wild-type lit-Requirement for Cyclin E
in Male Spermatogenesis termates (Figure 3B). No live cyclin E1/E2/embryos
were observed after E11.5. Surprisingly, histopathologicalCyclin E1/ mice were born with the expected Mende-
lian ratio and appeared indistinguishable from the wild- examination of the mutant embryos revealed that—
despite some growth retardation—these cyclin E-defi-type littermates. Detailed histopathological analyses re-
vealed normal morphogenesis in all tissues examined. cient embryos displayed normal morphogenesis and no
signs of pathological lesions. Also, analyses of yolk sacsThese cyclin E1-deficient animals displayed normal life
spans and appeared normal throughout their entire lives. revealed normal blood vessel formation and the pres-
ence of blood islands filled with numerous blood cellAlso, mice lacking cyclin E2 were born at the expected
frequencies and were initially indistinguishable from precursors (data not shown). In contrast, examination
of other extraembryonal tissues revealed a profoundcontrol littermates. However, we found that cyclin E2-
deficient males displayed reduced fertility, with ap- abnormality within the mutant placentas.
Specifically, we found that the layer of trophoblastproximately 50% of males being sterile. Our analyses
revealed that cyclin E2/ males displayed reduced tes- giant cells, usually very prominent in wild-type placentas
due to the giant size of trophoblast cell nuclei, was virtuallyticular size (Figure 2B) and greatly reduced sperm
counts (Figure 2C), as compared with wild-type lit- missing in mutant tissues. Instead, cyclin E1/E2/ pla-
centas contained a layer of greatly underdevelopedtermates. Microscopic analyses demonstrated a signifi-
cant testicular atrophy in cyclin E2/ mice (Figure 2A). “small” trophoblast cells with much smaller nuclei than
the corresponding layer in wild-type animals (Figure 3C).Testes of the mutant males displayed thinned walls of
the seminiferous tubules with great reduction in the Trophoblast giant cells represent a very unique popu-
lation that normally undergoes repeated rounds of DNAnumber of spermatogenetic cells. We also observed fre-
quent abnormal meiotic figures within the spermatocyte synthesis without intervening mitoses (endoreplication),
which leads to formation of giant nuclei containing uplayers (Figure 2A) and the presence of multinuclear giant
cells within the seminiferous epithelium. These observa- to 1000 N of DNA (Cross, 2000; Zybina and Zybina,
1996). The greatly diminished size of trophoblast nucleitions reveal that cyclin E2 is required for normal develop-
Cyclin E Ablation in the Mouse
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Figure 2. Testicular Abnormalities in Cyclin E-Deficient Mice
(A) Histologic sections of testes from 2- to 3-month-old wild-type (WT), cyclin E1/, and cyclin E2/ males, stained with hematoxylin and
eosin. Note the paucity of cells in the seminiferous tubules of cyclin E2/ animals and the presence of aberrant meiotic figures (arrow).
Original magnification 20. The right panel shows higher magnification of the boxed region.
(B) The mean testicular weight in 2- to 3-month-old WT (n  10), cyclin E1/ (n  12), and cyclin E2/ (n  12) males. Error bars denote
standard errors.
(C) Sperm counts in same experimental groups as in (B).
in cyclin E1/E2/ conceptuses suggested to us that of maternal blood flow, and production of angiogenic
factors and hormones that influence placental functionthe mutant trophoblast cells might fail to undergo normal
endoreplicative cycles. To verify this hypothesis, we (Cross, 2000; Cross et al., 2002), we hypothesized that
the placental dysfunction due to trophoblast cell defectquantitated the DNA content in trophoblast giant cells
of wild-type mice and in the corresponding trophoblast might be the cause of lethality in cyclin E1/E2/ em-
bryos.cells of cyclin E1/E2/ animals by Feulgen staining.
Diploid cells of the maternal decidua were used to stan-
dardize our measurements. As expected, in wild-type E Type Cyclins Are Dispensable
for the Development of the Embryo Properplacentas, trophoblast giant cells contained up to 1000
N of DNA, with the majority of cells containing over To verify this hypothesis, we turned to the tetraploid
complementation rescue method (Eggan et al., 2001;100 N of DNA. In contrast, the DNA content of cyclin
E1/E2/ trophoblast cells was greatly reduced, with Tanaka et al., 1997). In this technique, two-cell-stage
embryos are collected from pregnant wild-type femalesvirtually all cells containing less than 100 N DNA (Figure
3D). These findings suggest that E type cyclins are re- and fused by a pulse of an electric current, yielding one-
cell tetraploid embryos. These embryos are then kept inquired for repeated rounds of endoreplication in tropho-
blast giant cells, and consequently, in the absence of E vitro for 2 days and develop into tetraploid blastocysts.
Mutant ES cells are then injected into tetraploid blasto-type cyclins, the trophoblast cells fail to undergo normal
endoreplicative cycles. Given the critical central func- cysts and the chimeric embryos are implanted into foster
females for further development. Importantly, tetraploidtion of trophoblast giant cells in placental physiology,
including invasion into the maternal tissues, formation blastocysts cannot contribute to the embryo proper but
can form normal placentas and other extraembryonicof the blood vessels in the labyrinth layer, promotion
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Figure 3. Phenotype of Cyclin E1/E2/ Embryos
(A) Survival of E1/E2/ embryos at various stages of development. Shown are the ratios between the numbers of observed live E1/E2/
embryos and the total numbers of embryos analyzed. Numbers in parentheses denote the dead E1/E2/ embryos observed at each time
point. In the right-hand column, the expected frequency of mutant embryos is shown.
(B) Appearance of viable WT and E1/E2/ embryos at day 10.75 of gestation.
(C) Histologic sections of placentas derived from WT and E1/E2/ embryos at day 10.5 of gestation. Trophoblast giant cell nuclei are
marked by arrows. Asterisks mark the decidual layer of the placentas (containing diploid cells). Original magnification 40.
(D) Ploidy distribution of trophoblast giant cells in wild-type placentas and the ploidy of trophoblast cells in the corresponding layer of
E1/E2/ placentas.
tissues (Tanaka et al., 1997). Hence, all cells in the devel- and we analyzed the development of the chimeric em-
bryos. We found that this procedure fully rescued theoping embryo are derived from the injected mutant ES
cells, while the extraembryonic tissues are formed by embryonal lethality, and we recovered viable cyclin
E1/E2/ embryos at all points of development andcells deriving from wild-type (tetraploid) blastocysts. We
reasoned that if the observed lethality in cyclin at postnatal day (P)1 (Figures 4A and 4B). Since even
wild-type embryos produced by tetraploid complemen-E1/E2/ embryos is indeed caused by the placental
failure, we should be able to rescue this lethality by tation often die at birth (Eggan et al., 2001), we were
not able to study cyclin E1/E2/ mice during postna-tetraploid complementation.
First, we mated cyclin E1/E2/ males and females, tal life.
The observed rescue of the embryonal lethality bycollected blastocysts at E3.5, and derived several inde-
pendent cyclin E1/E2/embryonal stem (ES) cell lines the tetraploid complementation method points to the
placental abnormality as a cause of death in cyclinusing conventional methods (Hogan et al., 1986). The
appearance and the proliferation rate of these cyclin E1/E2/ animals. Moreover, these analyses reveal
that the E type cyclins are not required for embryo devel-E-deficient ES cells were very similar to those of control
wild-type ES cells (data not shown). Next, we injected opment (with the exception of cardiovascular system,
see below).cyclin E1/E2/ ES cells into tetraploid blastocysts,
Cyclin E Ablation in the Mouse
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Figure 4. Rescue of Cyclin E1/E2/ Lethality by Tetraploid Blastocyst Complementation
(A) Survival of the rescued embryos at various stages of development.  indicates normal development;  indicates that a fraction of
embryos were found dead at this stage.
(B) Normal appearance of rescued E1/E2/ animals at postnatal day (P)1. A wild-type (WT) neonate is shown for comparison.
(C) Ploidy distribution of WT and cyclin E1/E2/ megakaryocytes cultured in vitro for 3 days in the presence of thrombopoietin. Peaks
representing each ploidy class are labeled.
(D) Cardiovascular abnormalities in cyclin E1/E2/ embryos. Magnetic resonance imaging of cardiac malformations in E1/E2/ embryos.
Scale bars  1 mm; axes: d, dorsal; v, ventral; r, right; l, left. All images are transverse sections from day 15.5 embryos. Panels 1, 3, and 5
are images from a wild-type embryo. Abbreviations: sas, secondary atrial septum; pas, primary atrial septum; ra, la, right and left atria,
respectively; rv, lv, right and left ventricles, respectively; ivs, interventricular septum; a-ao, ascending aorta; d-ao, descending aorta; ao-a,
aortic arch; pa, pulmonary artery; tr, trachea; and es, esophagus. Panel 6 is a 3D reconstruction (left oblique view) of normal cardiac anatomy;
note the aortic arch on the left of the trachea. Panels 2, 4, and 7 are images from a cyclin E-deficient embryo, and panel 8 is a 3D reconstruction
of mutant cardiac anatomy. These show a primum atrial septal defect (ASDp, panel 2), a ventricular septal defect (VSD, panel 4), and a right-
sided aortic arch that arises from the right ventricle (panels 7 and 8), i.e., double-outlet right ventricle.
Cardiovascular Abnormalities in Cyclin cyclin E-deficient hearts, both the aorta and the pulmo-
nary artery arose incorrectly from the right ventricle,E1/E2/ Embryos
While we detected live cyclin E1/E2/ embryos until giving rise to the so-called double-outlet right ventricle
(Figure 4D, panels 7 and 8). This indicates that E typeP1, we found that a fraction (approximately half) of mu-
tant embryos died between E15.5 and E18.5 (Figure 4A). cyclins are required for the normal development of atrio-
ventricular endocardial cushions and associated struc-To determine the cause of this lethality, we analyzed
cyclin E-deficient embryos by serial sectioning and by tures (Webb et al., 1998). Lastly, we detected multiple
abnormalities in the patterning of aortic arches (Figuremagnetic resonance imaging (Schneider et al., 2003).
These analyses revealed multiple cardiac abnormalities 4D, panels 7 and 8). Similar defects were reported in
mutant animals with abnormal neural crest migrationin cyclin E1/E2/ conceptuses. Specifically, mutant
embryos displayed ventricular septal defect (VSD) com- and patterning (Kirby and Waldo, 1995) and suggest that
E type cyclins may play a role in this process. Impor-bined with primum atrial septal defect (ASD), leading
to the appearance of common atrioventricular canal in tantly, very extensive histopathological analyses involv-
ing serial sectioning of the entire rescued cyclinmutant hearts (Figure 4D, panels 2 and 4). Moreover, in
Cell
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E1/E2/ embryos revealed normal morphogenesis in
all other compartments. These observations indicate
that the E type cyclins are largely dispensable for normal
development.
Requirement for E Type Cyclins in Endoreplication
of Megakaryocytes
In addition to trophoblast giant cells, the platelet precur-
sors, megakaryocytes, are another cell type that nor-
mally undergoes endoreplicative cycles. The availability
of rescued cyclin E-deficient embryos allowed us to
address the requirement for E type cyclins in endorepli-
cation in this compartment. To this end, we isolated
megakaryocytes from E14.5 wild-type and cyclin E-defi-
cient livers, cultured them in vitro in the presence of
thrombopoietin to stimulate endoreplicative cycles, and
determined the DNA content. As expected, wild-type
megakaryocytes displayed polyploid DNA content, with
the majority of cells containing 32 N of DNA. In contrast,
DNA content was clearly reduced in cyclin E1/E2/
megakaryocytes (Figure 4C), revealing impaired endore-
plication in the absence of E type cyclins. Together with
our earlier studies of trophoblast giant cells, these analy-
ses reveal that E type cyclins are required for endorepli-
cation of diverse mammalian cellular compartments.
Continuous Cell Cycling in the Absence
of E Type Cyclins
We next derived fibroblasts (MEFs) from rescued cyclin
E1/E2/ embryos, and we used them for cell cycle
and molecular studies. Analyses of in vitro cultured
early-passage cyclin E1/E2/ MEFs revealed that
these cells actively proliferated in vitro, with a higher
fraction of mutant cells residing in the G1 phase (Figure
5B). We also determined that the rate of the S phase
progression (incorporation of [3H]thymidine per 103 of S
phase nuclei per unit of time) was very similar in wild-
type and cyclin E1/E2/ cells (data not shown).
Detailed analyses of the in vitro proliferation rates
revealed that the proliferation of cyclin E-deficient cells
Figure 5. Analyses of Cyclin E-Deficient Embryos and In Vitro Cul-was modestly impaired compared with wild-type con-
tured Mouse Embryonal Fibroblaststrols. We found that after 7 days of in vitro culture, cyclin
(A) Western blot analyses of the retinoblastoma protein, pRB, cyclinE-deficient cells on average increased cell number 30-
A, and p27Kip1 in wild-type (WT) and E1/E2/ embryos (left) andfold, i.e., 71.3% of the increase seen in wild-type con-
MEFs. The activity of cyclin A-associated kinase was also deter-trols (Figure 5C). These findings are consistent with
mined using histone H1 as a substrate.
apparently normal proliferation of cells within cyclin (B) Cell cycle distribution of asynchronously growing mouse embryo
E1/E2/ embryos. Since during repeated in vitro pas- fibroblasts cultured in vitro. Cells were pulsed with bromodeoxyuri-
dine (BrdU) for 1 hr and then stained with anti-BrdU antibodies andsaging cyclin E-deficient cells underwent replicative cri-
with propidium iodide followed by FACS analysis. The percentagessis earlier (passage four) compared to wild-type cells
of cells in particular phases of cell cycle are shown.(P7), all experiments described in this paper used cells
(C) In vitro proliferation of wild-type and cyclin E-deficient fibro-freshly explanted from embryos (P0) or at P1 and P2.
blasts. Equal amounts of cells were plated at the beginning of the
E type cyclins were postulated to play a key role in experiment. Cell numbers were determined every day for total of 7
the phosphorylation of the retinoblastoma protein (Har- days. Values shown are means of three independent experiments
utilizing cells derived from four E1/E2/ and four control embryos.bour et al., 1999; Lundberg and Weinberg, 1998), the
Error bars denote standard deviation.induction of cyclin A (Zerfass-Thome et al., 1997), and
in the degradation of the cell cycle inhibitor p27Kip1
(Sheaff et al., 1997). Importantly, absence of any of these
events is predicted to arrest cell cycling. Hence, prolifer- E-deficient embryos and MEFs versus their wild-type
counterparts, using Western blotting. We found that theation of cyclin E1/E2/ cells is very surprising, and
it is hard to reconcile with our current understanding of appearance of phosphorylated species of pRB was simi-
lar in wild-type and mutant samples (Figure 5A), reveal-cell cycle progression.
We started our molecular analyses by comparing the ing that at least at this level of resolution, E type cyclins
are not required for normal pRB phosphorylation. More-phosphorylation of the retinoblastoma protein in cyclin
Cyclin E Ablation in the Mouse
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over, we found that the levels of cyclin A, as well as the noted, however, that the overall extent of pRB phosphor-
ylation was slightly lower in mutant cells (Figures 6Blevels of cyclin A-associated kinase, were similar in wild-
type and mutant cells (Figure 5A). Hence, the activity of and 6C).
Phosphorylation and functional inactivation of pRB iscyclin E is not required for the induction of cyclin A.
Based on our additional analyses (see below), we pro- expected to liberate E2F transcription factors, leading
to the induction of E2F target genes (Dyson, 1998).pose that in cyclin E1/E2/ cells, the phosphorylation
of pRB is carried out by cyclin A. Moreover, we found Hence, we asked whether these E2F targets are normally
induced in the absence of cyclin E. Our analyses re-that the levels of p27Kip1 did not differ between wild-
type and mutant cells and embryos (Figure 5A), again vealed that several known E2F targets, such as CDC6,
CDC45, and cyclin A, are induced normally in cyclinrevealing that the levels of this inhibitor can be held in
check without any contribution from E type cyclins. E1/E2/ cells (Figure 6D and data not shown). Collec-
tively, these observations essentially rule out the ab-In addition to its well-documented cell cycle functions,
E type cyclins were postulated to play a key role in sence of pRB phosphorylation as the cause of the failure
of S phase entry in E1/E2/ cells.duplication of centrosomes, initiation of DNA replication,
and histone biosynthesis (see Introduction). However,
staining of cyclin E1/E2/ MEFs with the centrosomal Cyclin E and MCM Loading into DNA
marker  tubulin revealed normal appearance of this Replication Origins
organelle in mutant cells (data not shown). Moreover, Recent work of Coverley et al. (2002) revealed that in a
relatively normal cell cycling of mutant cells in vitro and cell-free in vitro reconstitution system, cyclin E triggers
normal development of cyclin E-deficient embryos im- loading of the MCM proteins into DNA replication origins
plies that both DNA and histones can be synthesized during G0→S progression. These findings, together with
normally in the absence of cyclin E activity. Collectively, our observations that cyclin E1/E2/ cells failed to
these results indicate that contrary to the widely held normally enter the S phase from the G0 state, suggested
view, E type cyclins are largely dispensable for continu- to us that mutant cells may be unable to incorporate
ous cell cycling. MCM into their DNA replication origins. To test this pos-
sibility, we stimulated wild-type and mutant cells to re-
enter the cell cycle, harvested cells at various timeCritical Requirement for E Cyclins
in Cell Cycle Reentry points, and prepared protein lysates. We then separated
the proteins into chromatin bound and chromatin un-Next, we analyzed the ability of cyclin E1/E2/ cells
to reenter the cell cycle from the quiescent G0 state. bound free fractions and examined the presence of
MCM2 in these fractions by Western blotting. As ex-To this end, we arrested cells in G0 phase by serum
deprivation, stimulated them to reenter the cell cycle by pected (Madine et al., 2000; Stoeber et al., 1998), in wild-
type cells, MCM2 was not bound to DNA in the G0 andserum readdition, and monitored their entry into S phase
by measuring thymidine incorporation. As expected, in early G1 cells, but it became associated with chromatin
approximately 12 hr after serum readdition (Figure 7A),wild-type cells synchronously entered the S phase start-
ing at 12 hr after serum readdition. In contrast, quiescent coinciding with the appearance of cyclin E kinase activ-
ity (data not shown). In contrast, MCM2 failed to associ-cyclin E1/E2/ cells were unable to normally reenter
the S phase (Figure 6A). In an alternative approach, cells ate with the DNA in cyclin E1/E2/ cells through the
entire observation period (Figure 7A). Importantly, wewere rendered quiescent by contact inhibition and were
then triggered to reenter the cell cycle by replating under verified that the levels of unbound, free MCM2 were very
similar in wild-type and cyclin E1/E2/ cells (Figurelow-density conditions. Again, cells lacking cyclin E
were unable to enter the S phase (data not shown). We 7A, bottom). Hence, cyclin E-deficient cells contain nor-
mal levels of MCM2 but fail to induce its loading intoconcluded that in the absence of E type cyclins, mutant
cells are unable to reenter the cell cycle from the quies- DNA replication origins during cell cycle reentry.
These findings prompted us to analyze loading of vari-cent G0 state.
In order to understand the molecular basis of this ous other components of the prereplicative complexes
onto DNA replication origins during G0→S phase pro-requirement for E type cyclins in cell cycle reentry, we
first focused on the phosphorylation of the retinoblas- gression of wild-type and mutant cells. As expected
(Madine et al., 2000; Stoeber et al., 1998), we found thattoma protein. We compared the pRB phosphorylation
at time zero and at 18 hr poststimulation, a time where in wild-type cells, the ORC2 protein remained associ-
ated with DNA replication origins at all points during cellwild-type cells were at the peak of the S phase progres-
sion (Figure 6A). Surprisingly, we found that pRB was cycle reentry. CDC6 was loaded onto DNA at approxi-
mately 12 hr, followed by DNA loading of the MCM atclearly phosphorylated in cyclin E1/E2/ cells (Figure
6B). Analyses of time course of pRB phosphorylation 12–15 hr (Figure 7B). In cyclin E-deficient cells, the ORC2
protein was also constitutively associated with DNA,following serum stimulation revealed that in wild-type
cells, hyperphosphorylated pRB species started to ap- and CDC6 was loaded at a similar time as in the wild-
type cells. However, as we observed before, mutantpear at 12 hr poststimulation, concomitant with appear-
ance of cyclin E-associated kinase (Figure 6C). In cyclin cells were deficient in MCM loading (Figure 7B). These
analyses reveal that the assembly of the prereplicativeE1/E2/ cells, pRB phosphorylation was delayed by
2–3 hr, and it coincided with the appearance of cyclin complexes is blocked in cyclin E1/E2/ cells at the
MCM loading stage.A-associated kinase (Figure 6C and data not shown).
These analyses suggest that in mutant cells, cyclin A is Relatively normal proliferation of continuously cycling
cyclin E1/E2/ cells, documented above, promptedresponsible for bringing about pRB phosphorylation. We
Cell
438
Figure 6. Impaired Cell Cycle Reentry in
Cyclin E-Deficient Cells
Wild-type and E1/E2/ mouse embryonal
fibroblasts (MEFs) were rendered quiescent
by serum deprivation and then were restimu-
lated to reenter the cell cycle by serum read-
dition.
(A) Entry into the S phase was gauged by
measuring [3H] thymidine uptake.
(B) Phosphorylation status of the retinoblas-
toma protein (pRB) was determined by West-
ern blotting at time zero and 18 hr after the
stimulation. ppRB denotes hyperphosphory-
lated pRB.
(C) pRB phosphorylation status at different
time points following serum stimulation was
determined by Western blotting (top). Cyclin
E- and cyclin A-associated kinase activities
were determined in the same samples using
histone H1 as a substrate (middle and bot-
tom). Right-hand panel shows control immu-
noprecipitation with anti-cyclin E antibody
using extracts from continuously growing
wild-type (WT) and E1/E2/ MEFs. Cyclin
E-associated kinase activity was determined
as above.
(D) The levels of known E2F targets, CDC45,
and CDC6, were determined by Western
blotting.
us to analyze the chromatin association of MCM in these Resistance of Cyclin E-Deficient Cells
to Oncogenic Transformationcells. Our analyses revealed that in contrast to cells
reentering the cell cycle from the quiescent G0 state, Lastly, we asked whether the absence of E type cyclins
alters the response of E1/E2/ cells to various onco-continuously cycling E1/E2/ cells displayed normal
loading of MCM2, as well as of ORC2 and CDC6 (Figure genic stimuli. First, we infected wild-type and cyclin
E1/E2/ MEFs with retroviruses encoding the c-Myc7C). Collectively, these results strongly suggest that
cyclin E activity is critically required for loading of MCM oncogene, selected the infected cells, and plated them
at low densities. While wild-type cells formed numerousinto prereplication complexes during G0→S phase pro-
gression, but not in continuously cycling cells, as postu- colonies following Myc expression, cyclin E1/E2/
cells failed to do so (Figure 8). Importantly, we verifiedlated by Coverley et al. (2002). Consequently, in the
absence of E type cyclins, mutant cells fail to assemble that the levels of the ectopically expressed Myc were
very similar in wild-type and mutant cells (data notnormal prereplication complexes during G0→S progres-
sion, explaining an inability of mutant cells to reenter shown).
Next, we infected cells with retroviruses encoding on-the cell cycle. We note here that a similar critical role
for cyclin E in MCM loading was postulated to operate cogene pairs: H-Ras plus c-Myc, or with H-Ras plus
dominant-negative (DN) p53, or H-Ras plus E1A, andin endoreplication (see Discussion).
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On the other hand, we found that cyclin E is essential for
normal development of mammalian placentas. Similar
results were independently obtained by T. Parisi et al.
(submitted). Intriguingly, recent reports indicate that
mice lacking other components of the cell cycle machin-
ery, namely the retinoblastoma protein (Wu et al., 2003),
as well as the E2F partner DP1 (Kohn et al., 2003), also
die due to placental abnormalities, revealing the specific
requirement for these proteins in extraembryonal devel-
opment.
It is widely assumed that E type cyclins are critically
required for normal proliferation of virtually all mamma-
lian cell types. E type cyclins were postulated to contrib-
ute to pRB inactivation (Harbour et al., 1999; Lundberg
and Weinberg, 1998), control centrosome duplication
(Hinchcliffe et al., 1999; Okuda et al., 2000), trigger the
initiation of DNA replication (Arata et al., 2000; Krude et
al., 1997), control histone biosynthesis via phosphoryla-
tion of p220NPAT (Ma et al., 2000; Zhao et al., 2000), acti-
vate E2F-5 (Morris et al., 2000), and bind and activate
CDC25 phosphatase (Hoffmann et al., 1994). In several
instances, the relevant function was uniquely ascribed
to cyclin E, but not to other cyclins. However, our obser-
vations that nearly normal mouse development takes
place in the absence of E type cyclins indicate that ourFigure 7. Defective MCM Loading in Cyclin E-Deficient Cells
current understanding of the cell cycle machinery needs
(A and B) Wild-type (WT) and cyclin E1/E2/ mouse embryonal
to be reevaluated.fibroblasts (MEFs) were rendered quiescent by serum deprivation
Our analyses of in vitro cultured cyclin E-deficientand then were restimulated to reenter the cell cycle by serum readdi-
tion. (A) Protein extracts were separated into chromatin bound and cells revealed that E type cyclins are not essential for
chromatin unbound free fractions, and the levels of MCM2 in these continuous cell cycling but are critically required for cell
fractions were determined by Western blotting. (B) The levels of cycle reentry. Since most cells of the developing embryo
ORC2, CDC6, and MCM2 in the chromatin bound fraction were are in an actively proliferating state (Kaufman and Bard,
determined by Western blotting.
1999), these observations likely explain normal em-(C) The levels of ORC2, CDC6, and MCM2 in the chromatin bound
bryonal development seen in cyclin E1/E2/ animals.fraction of continuously proliferating MEFs.
Active proliferation of cyclin E-deficient cells indicates
that all functions specifically ascribed to E type cyclins
can be carried out by other proteins. For instance, ourscored the ability of these oncogenes to transform cyclin
analyses indicate that cyclin A mediates phosphoryla-E-deficient MEFs using focus-forming assay. In each
tion of pRB in E1/E2/ fibroblasts, and this phosphor-case, equal expression of the introduced oncogenes
ylation occurs at a time when cyclin A normally phos-was verified in wild-type versus mutant cells by Western
phorylates pRB in wild-type cells.blotting (data not shown). We found that cyclin
E1/E2/ monolayers failed to form foci following in-
troduction of oncogenic Ras plus Myc or Ras plus DN E Type Cyclins and MCM Loading
During continuous cell cycling, binding of MCM to thep53 (Figure 8). In the case of H-Ras plus E1A oncogenes,
we observed the presence of some putative foci in cyclin replication origins occurs immediately after the exit from
mitosis, i.e., in the absence of any cyclin E-CDK activityE1/E2/ monolayers. However, the number of these
foci was reduced approximately 10- to 12-fold, as com- (Mendez and Stillman, 2000). As the cells traverse the
G1 and enter the S phase, cyclin E-CDK activity is be-pared wild-type cells, and cyclin E-deficient foci displayed
very flattened appearance (Figure 8). We concluded that lieved to be responsible for the origin firing by phosphor-
ylating as yet unidentified targets (Krude et al., 1997;mutant cells display greatly reduced susceptibility to
oncogenic transformation. Stoeber et al., 1998). Cyclin E action is thought to allow
loading of CDC45 onto replication origins, which results
in origin melting and recruitment of polymerase  (ArataDiscussion
et al., 2000; Zou and Stillman, 2000). Our demonstration
that cyclin E1/E2/ cells proliferate in vivo and inIn this study, we tested the requirement for cyclin E in
mouse development by genetic means. Contrary to the vitro suggests that in continuously growing cells, other
critical steps in origin firing are likely carried out byprevailing view, we found that cyclin E is largely dispens-
able for normal mouse embryogenesis. Thus, while cyclin A or by other proteins.
In contrast to active continuous cell cycling, we foundcyclin E was shown to be critically required for the devel-
opment of Drosophila melanogaster (Knoblich et al., that cyclin E-deficient cells were unable to normally re-
enter the cell cycle from the quiescent G0 state. Impor-1994) and Caenorhabditis elegans (Fay and Han, 2000),
this is clearly not the case in the mammalian embryos. tantly, these cyclin E1/E2/ cells failed to enter S
Cell
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Figure 8. Resistance of Cyclin E-Deficient
Cells to Oncogenic Transformation
Appearance of crystal violet-stained plates
(left) and the mean number of foci or colonies
seen in wild-type and cyclin E1/E2/ MEFs
infected with retroviruses encoding indicated
oncogenes. Error bars denote SD.
In the case of v-Ha-Ras plus E1A infection,
low magnification of the crystal violet-stained
monolayers and higher magnification of un-
stained foci (bottom) is shown.
phase despite normal induction of cyclin A and cyclin our E1/E2/ cells, this window of opportunity for
MCM loading fails to open, due to the absence of E typeA-associated kinase activity and nearly normal phos-
phorylation of the retinoblastoma protein. Thus, cyclin cyclins, explaining an inability of mutant cells to reenter
the cell cycle. These observations, together with normalE plays a specific, critical function in G0→S progression,
and this function cannot be carried out by other cyclins. MCM loading in continuously cycling E1/E2/ cells,
reveal that the molecular basis of the S phase entryOur molecular analyses revealed that in the absence of
E type cyclins, mutant cells fail to normally load MCM differs, depending on whether cells emerge from the M
or G0 phase.proteins onto their DNA replication origins.
Unlike in continuously cycling cells, in quiescent G0
state, MCM and CDC6 are displaced from chromatin E Type Cyclins and Endoreplication
In addition to G0→S transition of mammalian cells, cyclinand must be reloaded during cell cycle reentry (Madine
et al., 2000; Stoeber et al., 1998). Coverley et al. (2002) E was postulated to cause loading of MCM proteins onto
DNA replication origins also in another very differentshowed that in cell-free in vitro reconstitution systems,
cyclin E activity is critically required for loading of MCM setting, namely during endoreplicative cycles of Dro-
sophila melanogaster salivary glands. Thus, Su andonto replication origins during G0→S phase transition.
Importantly, the work of Coverley et al. (2002) reveals O’Farrell (1998) observed that MCM2 becomes chroma-
tin bound in less than 8 min after inducible activationthat cyclin E must act before cyclin A to allow normal
DNA replication in this setting, and addition of cyclin A of cyclin E in endoreplicating salivary glands and that
this relocalization of MCM2 precedes cyclin E-inducedto in vitro reactions prior to cyclin E completely blocked
MCM loading and subsequent S phase entry. Hence, S phase entry. Based on these observations, Su and
O’Farrell (1998) postulated that in normal endoreplica-Coverley et al. (2002) postulate that during normal G0→S
phase progression, a window of opportunity for MCM tive cycles, activation of cyclin E triggers MCM relocal-
ization to DNA replication origins. It is very tempting toloading exists, which is opened by cyclin E action and
closed as soon as cyclin A appears. We believe that in speculate that both the inability of cyclin E1/E2/
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gous recombination at the cyclin E2 locus. The recombinant ES cellscells to reenter the cell cycle and the endoreplicative
were then used to generate cyclin E2-deficient and cyclin E1/E2/defect seen in E1/E2/ mice are caused by the same
animals, using standard procedures (Sicinski et al., 1995).molecular defect, namely defective binding of MCM to
replication origins in the absence of cyclin E.
Histologic AnalysesRegardless of the exact molecular mechanism of the
Organs or embryos were fixed in Bouin’s fixative (Sigma) and em-endoreplicative defect seen in cyclin E-deficient mice,
bedded in paraffin. Histologic sections were stained with hematoxy-our results reveal that cyclin E is required for endorepli-
lin and eosin. Sperm counts were performed as described (Searle
cation in mammalian cells and that this requirement and Beechey, 1974). The number of sperm cells was expressed as
operates in both trophoblast giant cells and in megakar- the number of cells per both epididymi.
yocytes. Importantly, cyclin E was previously postulated For quantification of DNA ploidy in trophoblast giant cells, placen-
tas were collected from E10.5 wild-type and mutant embryos, fixedto play key role in endoreplication occurring in Drosoph-
in 4% paraformaldehyde and embedded in paraffin. 5 m thickila (Duronio and O’Farrell, 1995; Knoblich et al., 1994;
sections were cut and stained with Feulgen stain. Four wild-typeSauer et al., 1995), revealing that this function for cyclin
and four cyclin E1/E2/ placentas were analyzed. Images were
E is conserved during evolution. quantified using Scion Image software (Scion Corporation, Frederick
MD). The ploidy of trophoblast giant cells was expressed relative
to diploid decidual cells.E Type Cyclins and Oncogenic Transformation
Our analyses revealed that cyclin E-deficient cells are
resistant to transformation by various oncogene pairs. Derivation of Embryonal Stem Cells and Tetraploid
Blastocyst ComplementationThis observation may seem unexpected. However, re-
Cyclin E1/E2/ ES cells were derived from E3.5 blastocysts es-cent work of Zou et al. (2002) showed that cells lacking
sentially as described (Hogan et al., 1986). Tetraploid blastocystCDK4 are also oncogene resistant, but proliferate nor-
complementation was performed as described (Eggan et al., 2001).
mally under nononcogenic conditions. The resistance Briefly, two-cell embryos were collected from B6D2F1 mice and
of CDK4/ cells to oncogenic transformation has been fused with two electrical pulses of 90 V applied for 30 s to produce
traced to the increased levels of the cell cycle inhibitor one-cell tetraploid embryos. Embryos were then incubated in KSOM
media (Specialty Media) for 2 days at 37	C and developed intop21Cip1 in these cells (Zou et al., 2002). Importantly, the
tetraploid blastocysts. ES cells were injected into tetraploid blasto-levels of p21Cip1 and of other cell cycle inhibitors remain
cysts using piezo micromanipulator (Primetech, Japan), and chime-unperturbed in cyclin E-deficient cells expressing acti-
ric embryos were implanted into pseudopregnant recipient females
vated oncogenes, as compared to oncogene-express- for further development.
ing wild-type cells (data not shown). However, we be-
lieve that the resistance of cyclin E-deficient and
Isolation, In Vitro Culture, and Analyses of MegakaryocytesCDK4/ cells to transformation can be explained by
Cells were isolated from E14.5 livers and cultured for 3 days in
the same mechanistic principle. Thus, we propose that DMEM 10% fetal bovine serum (Sigma) supplemented with 1% tis-
there is a critical threshold for cyclin-associated kinase sue-culture supernatant from a murine c-Mpl ligand-producing cell
activities that is required for oncogenic cell cycling. This line (kindly provided by Dr. R. Shivdasani). Megakaryocytes were
stained with FITC-conjugated anti-CD41 antibody (PharMingen) to-threshold can be compromised either by decreasing the
gether with propidium iodide, and DNA content among CD41-posi-activity of kinases (by upregulating p21Cip1, in the case
tive cells was determined by flow cytometry.of CDK4/ cells) or by eliminating the activators of ki-
nases, cyclins (in the case of E1/E2/ cells).
Magnetic Resonance ImagingAmplification of the cyclin E gene, located on chromo-
Paraformaldehyde-fixed embryos were embedded in 1% agarosesome 19q12, and overexpression of cyclin E protein are
containing 2 mM gadolinium-diethylenetriamine pentaacetic anhy-seen very frequently in human malignancies (Donnellan
dride (Gd-DTPA) and imaged using an 11.7 Tesla vertical magnetand Chetty, 1999). In the case of breast cancers, ele-
interfaced to a Bruker Avance spectrometer as described (Schneider
vated levels of cyclin E strongly correlate with poor clini- et al., 2003). 3D datasets were analyzed and surface reconstructions
cal outcome (Porter et al., 1997). Thus, elucidation of generated using Amira 3.0 (TGS Europe).
the molecular functions for cyclin E in normal prolifera-
tion may help to understand how these functions are
Western Blotting and Chromatin Binding Analyses
subverted in human neoplastic disease. Blots were probed with antibodies against pRB (Pharmingen), cyclin
A (Santa Cruz), p27Kip1 (Santa Cruz), MCM2 (Pharmingen), CDC6
(Santa Cruz), and ORC2 (kindly provided by Dr. A. Dutta). As second-Experimental Procedures
ary antibodies, peroxidase-conjugated IgG (Jackson ImmunoRe-
search) was used, followed by enhanced chemiluminescence detec-Generation of Cyclin E1- and E2-Deficient Mice
The cyclin E1 gene-targeting construct was assembled by removing tion (Amersham Pharmacia).
For kinase assays, 100 g of proteins was incubated with anti-a 10 kb NotI-ScaI fragment of the murine cyclin E1 gene (containing
coding exons 2–11) and replacing it with the neomycin phospho- cyclin E antibody or with anti-cyclin A antibody conjugated to aga-
rose beads (Santa Cruz). Immunoprecipitations and kinase reactionstransferase (neo) gene. The construct was electroporated into em-
bryonal stem (ES) cells and clones were selected as described (Si- were performed as described (Geng et al., 1999).
Separation of proteins into chromatin bound and free fractionscinski et al., 1995). Ten out of 198 ES cell clones analyzed underwent
homologous recombination at the cyclin E1 locus. Two recombinant was performed using standard methods (Arata et al., 2000; Madine
et al., 2000). Briefly, cells were incubated for 15–20 min on ice inES cell clones were used to generate cyclin E1-deficient animals.
Cyclin E2 gene-targeting vector was generously provided by Drs. 0.1% Nonident P-40-containing CSK buffer (10 mM PIPES [pH 7.0],
100 mM NaCl, 3 mM MgCl2, and 300 mM sucrose). Insoluble fractionsBruno Amati and Andreas Beck. The construct was modified by
replacing a 14kb NotI-SpeI fragment of the cyclin E2 gene (encoding were collected by centrifugation at 5000 rpm for 5 min at 4	C and
added to SDS sample buffer prior to SDS-PAGE. In each samplecoding exons 1–8) with the puromycin resistance gene. Such modi-
fied gene targeting construct was electroporated into cyclin E1/ analyzed, proteins deriving from 106 nuclei were used for Western
blot analyses.ES cells. Four out of 320 ES cell clones analyzed underwent homolo-
Cell
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Cell Proliferation Analyses and Oncogenic Dyson, N. (1998). The regulation of E2F by pRB-family proteins.
Genes Dev. 12, 2245–2262.Transformation Assays
Cells were grown in 10% fetal bovine serum in DMEM. For cell cycle Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M.,
reentry, cells were starved in serum-free DMEM for 48–72 hr before Rideout, W.M., 3rd, Yanagimachi, R., and Jaenisch, R. (2001). Hybrid
being restimulated with 10% fetal bovine serum for indicated times. vigor, fetal overgrowth, and viability of mice derived by nuclear
Alternatively, cells were kept at full confluence for 3 days, released cloning and tetraploid embryo complementation. Proc. Natl. Acad.
from quiescence by being replated at low density (20%–30% conflu- Sci. USA 98, 6209–6214.
ent density), and harvested at indicated time points. For growth-
Fay, D.S., and Han, M. (2000). Mutations in cye-1, a Caenorhabditis
curve assays, cells were plated at 3  104 cells per well in 12-well
elegans cyclin E homolog, reveal coordination between cell-cycle
plates. At indicated times, cells were quantified.
control and vulval development. Development 127, 4049–4060.
Oncogenic transformation assays on cell monolayers were per-
Geisen, C., and Moroy, T. (2002). The oncogenic activity of cyclinformed on freshly explanted (passage zero) MEFs as described
E is not confined to Cdk2 activation alone but relies on several other,(Zou et al., 2002) using the following retroviruses: LXSN vector for
distinct functions of the protein. J. Biol. Chem. 277, 39909–39918.coexpression of DNp53 (GSE56) plus H-RasVal12 (kindly provided by
Geng, Y., Whoriskey, W., Park, M.Y., Bronson, R.T., Medema, R.H.,Dr. A. Gudkov), pLPC-E1A-ires-H-rasVal12 (kindly provided by Dr. S.
Li, T., Weinberg, R.A., and Sicinski, P. (1999). Rescue of cyclin D1Lowe), pBabe-puro-H-RasVal12, and pBabe-hygro-c-Myc. Immortali-
deficiency by knockin cyclin E. Cell 97, 767–777.zation with Myc was performed using pBabe-hygro-c-Myc retrovirus
as described (Bouchard et al., 1999). Foci and colonies were stained Geng, Y., Yu, Q., Whoriskey, W., Dick, F., Tsai, K.Y., Ford, H.L.,
with crystal violet and quantified after 2–3 weeks. Biswas, D.K., Pardee, A.B., Amati, B., Jacks, T., et al. (2001). Expres-
sion of cyclins E1 and E2 during mouse development and in neopla-
sia. Proc. Natl. Acad. Sci. USA 98, 13138–13143.Acknowledgments
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